SCHEMBL3783777

SCHEMBL3783777

CC(=O)SOc1cccc(N)c1-c1cccc(N)c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 1/20 0.41
ALDH1A1 P00352 3/20 0.36
MCL1 Q07820 1/20 0.36
MAP4K4 O95819 1/20 0.36
MAOA P21397 1/20 0.36
MAPT P10636 3/20 0.35
FYN P06241 1/20 0.34
CYP3A4 P08684 2/20 0.34
KDM4E B2RXH2 2/20 0.34
RAB9A P51151 2/20 0.34
CYP17A1 P05093 1/20 0.33
CYP19A1 P11511 1/20 0.33
CYP11B1 P15538 1/20 0.33
CYP11B2 P19099 1/20 0.33
LMNA P02545 1/20 0.33
PKM P14618 1/20 0.33
RXFP1 Q9HBX9 1/20 0.33
TUBB4A P04350 2/20 0.33
TUBB P07437 2/20 0.33
TUBA3C P0DPH7 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3789887 0.88 MAPT (0.38) SMN1; SMN2ALDH1A1MAPTKDM4ERAB9A
SCHEMBL3786673 0.85 MTOR (0.32) SMN1; SMN2ALDH1A1MAPTKDM4ERAB9A
SCHEMBL3790372 0.82 SMN1; SMN2 (0.43) SMN1; SMN2ALDH1A1MCL1MAP4K4MAOA
SCHEMBL3785607 0.81 MAP4K4 (0.40) SMN1; SMN2ALDH1A1MCL1MAP4K4MAOA
SCHEMBL3789776 0.81 ADRA2A (0.43) ALDH1A1MAP4K4MAOAMAPTKDM4E
SCHEMBL3792743 0.81 MCL1 (0.43) SMN1; SMN2ALDH1A1MCL1MAP4K4MAOA
SCHEMBL3785270 0.81 MCL1 (0.43) SMN1; SMN2ALDH1A1MCL1MAP4K4MAOA
SCHEMBL3783966 0.79 ADORA2A (0.38) SMN1; SMN2ALDH1A1MAOAMAPTKDM4E
SCHEMBL3781473 0.78 TUBB4A (0.40) SMN1; SMN2ALDH1A1MCL1MAP4K4MAOA
SCHEMBL3792023 0.78 PTGDR2 (0.47) SMN1; SMN2ALDH1A1MCL1MAP4K4MAOA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100087680-A1 METHOD FOR PRODUCING BIARYL COMPOUND SUMITOMO CHEMICAL COMPANY LIMITED (JP) 2010-04-08 US disclosed
EP-1914221-A1 PROCESS FOR PRODUCING BIARYL COMPOUND Sumitomo Chemical Company, Limited (JP) 2008-04-23 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100087680-A1 METHOD FOR PRODUCING BIARYL COMPOUND NISCH, BLVRB, BBOX1 SMN1; SMN2 4524/4885ALDH1A1 4339/4885MCL1 3100/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.